| 2025-11-07 |
详情>>
股本变动：
变动后总股本3599.36万股
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-8.24美元,归母净利润-2.94亿美元,同比去年增长-27.58%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-10-04 |
复牌提示：
2025-10-03 14:36:08 停牌，复牌日期 2025-10-03 16:07:47
|
| 2025-10-03 |
详情>>
内部人交易：
Hendriks Han股份减少2067.00股
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-5.18美元,归母净利润-1.84亿美元,同比去年增长-28.75%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-2.22美元,归母净利润-7900万美元,同比去年增长-4.64%
|
| 2025-04-29 |
股东大会：
将于2025-06-25召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, nine directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2026 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the year ending December 31, 2025 and to authorize, by binding vote, the Audit Committee of the Company’s Board of Directors (the “Board”) to set the auditors’ remuneration;
4.To approve a proposal to grant the Board authority to issue shares under Irish law;
5.To approve a proposal to grant the Board authority to opt out of statutory pre-emption rights, with respect to up to a maximum of 10% of issued ordinary share capital, under Irish law;
6.To set the price range for the Company’s re-issuance of treasury shares;
7.To approve amendments to the Company’s Omnibus Incentive Plan;
8.To allow the voluntary forfeiture of stock options by the Company’s CEO, CFO and CLO, for no consideration, to be returned to the Company’s Omnibus Incentive Plan;
9.Transacting any other business that may properly come before the Annual Meeting.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-9.86美元,归母净利润-3.48亿美元,同比去年增长50.31%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-11.99美元,归母净利润-4.31亿美元,同比去年增长-197.93%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-6.53美元,归母净利润-2.31亿美元,同比去年增长47.15%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-4.06美元,归母净利润-1.43亿美元,同比去年增长63.99%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-11.34美元,归母净利润-3.98亿美元,同比去年增长-834.13%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-2.14美元,归母净利润-7550万美元,同比去年增长-54.4%
|
| 2024-04-29 |
股东大会：
将于2024-06-26召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, eleven directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2025 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the year ending December 31, 2024 and to authorize, by binding vote, the Audit Committee of the Company’s Board of Directors (the “Board”) to set the auditors’ remuneration;
4.To approve a proposal to grant the Board authority to issue shares under Irish law;
5.To approve a proposal to grant the Board authority to opt out of statutory pre-emption rights, with respect to up to a maximum of 10% of issued ordinary share capital, under Irish law;
6.To set the price range for the Company’s re-issuance of treasury shares;
7.Transacting any other business that may properly come before the Annual Meeting.
|
| 2024-02-23 |
详情>>
业绩披露：
2023年年报每股收益-19.88美元,归母净利润-7.01亿美元,同比去年增长-62.75%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-12.42美元,归母净利润-4.36亿美元,同比去年增长-565.09%
|
| 2023-05-01 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, eleven (11) directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2024 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the year ending December 31, 2023 and to authorize, by binding vote, the Audit Committee of the Company’s Board of Directors (the “Board”) to set the auditors’ remuneration;
4.To approve a proposal to grant the Board authority to issue shares under Irish law;
5.To approve a proposal to grant the Board authority to opt out of statutory pre-emption rights, with respect to up to a maximum of 10% of issued ordinary share capital, under Irish law;
6.To set the price range for the Company’s re-issuance of treasury shares;
7.To approve an amendment to the Company’s Omnibus Incentive Plan;
8.Transacting any other business that may properly come before the Annual Meeting.
|
| 2022-04-25 |
股东大会：
将于2022-06-14召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, thirteen (13) directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2023 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To ratify, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the year ending December 31, 2022 and to authorize, by binding vote, the Audit Committee of the Company’s Board of Directors (the “Board”) to set the auditors’ remuneration;
4.To approve a proposal to grant the Board authority to issue shares under Irish law;
5.To approve a proposal to grant the Board authority to opt out of statutory pre-emption rights, with respect to up to a maximum of 10% of issued ordinary share capital, under Irish law;
6.To approve amendments to the Memorandum and Articles of Association of Trinseo PLC (the “Constitution”) to remove the existing authorized class of preferred shares;
7.To set the price range for the Company’s re-issuance of treasury shares;
8.To approve an amendment and restatement of the Company’s Omnibus Incentive Plan;
9.Transacting any other business that may properly come before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-06-14召开股东大会
会议内容 ▼▲
- 1.After review of the reports required by Luxembourg law, to approve the proposed merger of the Company into Trinseo PLC, a public limited company incorporated under the laws of Ireland with company number 562693 and having its registered office at Riverside One, Sir John Rogerson's Quay, Dublin 2, D02 X576 (the "Merger"), in accordance with the common draft terms of merger dated April 23, 2021 (the "Common Draft Terms") whereby Trinseo PLC will acquire all assets and liabilities of the Company by universal succession of title, and the Company will cease to exist (the "Merger Proposal");
2.To approve an amendment to Article 7.1.1 of the Company's articles of association as amended and restated on June 20, 2018 (the "Articles") to increase the size of the Company's Board to a maximum of thirteen (13) directors (the "Board Increase Proposal").
3.Subject to approval of the Merger Proposal, to consider and approve, on a non-binding advisory basis, the proposed Memorandum and Articles of Association of Trinseo PLC (the "Proposed Constitution"), which are attached to this proxy statement as Annex B, which will be in effect at time of the Merger and which will effectively replace our Articles (the "Irish Constitution Proposal");
4.Subject to approval of the Merger Proposal, to consider and vote upon separate proposals to approve, on a non-binding advisory basis, the following material differences between our Articles and the Proposed Constitution which are being presented in accordance with the requirements of the Securities and Exchange Commission (the "SEC") as three separate advisory proposals (we refer to such proposals as the "Advisory Constitution Proposals"):Upon the effective date of the Merger, under the Proposed Constitution, Trinseo PLC will have a share capital of (i) 4,000,000,000 ordinary shares, par value $0.01 per share, (ii) 1,000,000,000 preferred shares, par value $0.01 per share and (iii) 25,000 deferred ordinary shares par value 1.00 per share, in comparison to the Articles which provides for a share capital of up to 50,000,000,000 shares, par value $0.01 per share;Under the Proposed Constitution, the board of directors of Trinseo PLC will have discretion to issue up to the authorized but unissued amount of Trinseo PLC's share capital for cash without preemptive rights for a period of five years from adoption, in comparison to the Articles which permit the Board to issue up to 20% of the existing share capital without offering those shares to existing shareholders and up to 100% of the existing share capital with preemptive rights, until 2023.Under the Proposed Constitution, shareholders wishing to nominate persons for election to the Board or to properly bring other business before an annual general meeting of shareholders must give timely notice to Trinseo PLC, which must be received not less than 90 nor more than 120 days prior to the first anniversary of the date Trinseo PLC's proxy statement for the prior year was first mailed to shareholders, in comparison to the Articles under which shareholders may bring nominations for directors for vote at an annual meeting if submitted 90 to 120 days prior to the annual meeting date.
5.Subject to the approval of the Merger Proposal, to approve the creation of distributable profits of Trinseo PLC under Irish law by reducing the entire share premium of Trinseo PLC (or such lesser amount as may be approved by the board of directors of Trinseo PLC) resulting from the allotment and issue of ordinary shares of Trinseo PLC pursuant to the Merger (the "Distributable Profits Proposal");
6.To elect twelve (12) directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2022 annual general meeting;
7.Subject to approval of the Board Increase Proposal, to elect Ms. Victoria Brifo as our thirteenth director, to serve for a term of one year expiring at the 2022 annual general meeting.
8.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
9.To approve, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers;
10.To approve changes to the Company's director compensation program;
11.To approve the Company's annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2020 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2020;
12.To approve the allocation of the results of the year ended December 31, 2020, including but not limited to the declaration of an annual dividend in the amount of all interim dividends declared and distributed since the Company's last annual general meeting of shareholders;
13.To approve the granting and discharge of the Company's directors and auditor for the performance of their respective duties during the year ended December 31, 2020;
14.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company's independent auditor for all statutory accounts required by Luxembourg law for the year ending December 31, 2021;
15.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company's independent registered public accounting firm for the year ending December 31, 2021.
|
| 2020-04-27 |
股东大会：
将于2020-06-09召开股东大会
会议内容 ▼▲
- 1.To elect nine (9) Class II directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2021 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To approve the Company’s annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2019 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2019;
4.To approve the allocation of the results of the year ended December 31, 2019;
5.To approve the granting and discharge of the Company’s directors and auditor for the performance of their respective duties during the year ended December 31, 2019;
6.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company’s independent auditor for all statutory accounts required by Luxembourg law for the year ending December 31, 2020;
7.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company’s independent registered public accounting firm for the year ending December 31, 2020;
8.To approve, as required by Luxembourg law, an annual dividend in the amount of all interim dividends declared since the Company’s last annual general meeting of shareholders;
9.To approve a new share repurchase authorization to repurchase the Company’s shares;
10.To approve an amendment to the Company’s Omnibus Incentive Plan.
|
| 2020-02-26 |
除权日：
美东时间 2020-04-08 每股派息0.40美元
|
| 2019-11-21 |
除权日：
美东时间 2020-01-08 每股派息0.40美元
|
| 2019-10-21 |
股东大会：
将于2019-11-20召开股东大会
会议内容 ▼▲
- 1.To elect two additional directors specifically named in the proxy statement, each to serve a term until the Company’s next annual meeting.
|
| 2019-09-25 |
除权日：
美东时间 2019-10-09 每股派息0.40美元
|
| 2019-06-20 |
除权日：
美东时间 2019-07-10 每股派息0.40美元
|
| 2019-04-30 |
股东大会：
将于2019-06-19召开股东大会
会议内容 ▼▲
- 1.To elect four Class II directors specifically named in the proxy statement, each to serve for a term of one year expiring at the 2020 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To approve the Company’s annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2018 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2018;
4.To approve the allocation of the results of the year ended December 31, 2018;
5.To approve the granting and discharge of the Company’s directors and auditor for the performance of their respective duties during the year ended December 31, 2018;
6.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company’s independent auditor for all statutory accounts required by Luxembourg law for the year ending December 31, 2019;
7.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company’s independent registered public accounting firm for the year ending December 31, 2019;
8.To approve a new share repurchase authorization to repurchase the Company’s shares in amount determined by the Company’s Board of Directors;
9.To approve an amendment to the Company’s Omnibus Incentive Plan.
|
| 2019-02-27 |
除权日：
美东时间 2019-04-10 每股派息0.40美元
|
| 2018-11-29 |
除权日：
美东时间 2019-01-08 每股派息0.40美元
|
| 2018-09-27 |
除权日：
美东时间 2018-10-09 每股派息0.40美元
|
| 2018-06-21 |
除权日：
美东时间 2018-07-10 每股派息0.40美元
|
| 2018-04-30 |
股东大会：
将于2018-06-20召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors specifically named in the proxy statement, each to serve for a term of three years expiring at the 2021 annual general meeting;
2.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
3.To approve the Company’s annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2017 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2017;
4.To approve the allocation of the results of the year ended December 31, 2017;
5.To approve an allocation to the Company's legal reserve;
6.To approve the granting and discharge of the Company’s directors and auditor for the performance of their respective duties during the year ended December 31, 2017;
7.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company’s independent auditor for all statutory accounts required by Luxembourg law for the year ending December 31, 2018;
8.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company’s independent registered public accounting firm for the year ending December 31, 2018.
|
| 2018-02-22 |
除权日：
美东时间 2018-04-10 每股派息0.36美元
|
| 2017-11-30 |
除权日：
美东时间 2018-01-08 每股派息0.36美元
|
| 2017-10-20 |
股东大会：
将于2017-11-28召开股东大会
会议内容 ▼▲
- 1.To elect one Class III director, Mr. Henri Steinmetz, to serve for a term until the 2020 annual general meeting of shareholders.
2.for the purpose of approving or authorizing any other business properly brought before the Extraordinary General Meeting of Shareholders.
|
| 2017-09-21 |
除权日：
美东时间 2017-10-09 每股派息0.36美元
|
| 2017-06-22 |
除权日：
美东时间 2017-07-07 每股派息0.36美元
|
| 2017-04-28 |
股东大会：
将于2017-06-21召开股东大会
会议内容 ▼▲
- 1.To elect four Class III directors specifically named in the proxy statement, each to serve for a term of three years;
2.To ratify the appointment by the Company’s board of directors (the “Board”) of (i) Philip Martens as a Class II director to fill the vacancy created by the resignation of Felix Hauser, with a remaining term of two years; and (ii) Joseph Alvarado as a Class I director to fill the vacancy created by the resignation of Michel Plantevin, with a remaining term of one year;
3.To approve changes to the Company’s director compensation program;
4.To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;
5.To approve the Company’s annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2016 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2016;
6.To approve the allocation of the results of the year ended December 31, 2016;
7.To approve the granting and discharge of the Company’s directors and auditor for the performance of their respective duties during the year ended December 31, 2016;
8.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company’s independent auditor for all statutory accounts required by Luxembourg law for the year ended December 31, 2017;
9.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company’s independent registered public accounting firm for the year ended December 31, 2017;
10.To authorize the Board’s share repurchase program.
Second, for the purpose of approving an extraordinary resolution in order:
11. To approve amendments to the Company’s Articles of Association as set forth in the accompanying proxy statement.
|
| 2017-02-21 |
除权日：
美东时间 2017-04-07 每股派息0.30美元
|
| 2016-12-01 |
除权日：
美东时间 2017-01-09 每股派息0.30美元
|
| 2016-09-28 |
除权日：
美东时间 2016-10-07 每股派息0.30美元
|
| 2016-06-22 |
除权日：
美东时间 2016-07-01 每股派息0.30美元
|
| 2016-05-03 |
股东大会：
将于2016-06-21召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors specifically named in the proxy statement, each to serve for a term of three years;
2.To ratify the Board's appointment of Stephen F. Thomas as director of the Board to fill a vacancy in Class III, with a remaining term of one year;
3.To ratify the Company's directors' compensation program;
4.To approve, on an advisory basis, of the compensation paid by the Company to its named executive officers;
5.To approve the Company's annual accounts prepared in accordance with accounting principles generally accepted in Luxembourg for the year ended December 31, 2015 and its consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States including a footnote reconciliation of equity and net income to International Financial Reporting Standards for the year ended December 31, 2015;
6.To approve the allocation of the results of the year ended December 31, 2015;
7.To approve the granting and discharge of the Company's directors and auditor for the performance of their respective duties during the year ended December 31, 2015;
8.To ratify the appointment of PricewaterhouseCoopers Société cooperative to be the Company's independent auditor for all statutory accounts required by Luxembourg law for the year ended December 31, 2016;
9.To ratify the appointment of PricewaterhouseCoopers LLP to be the Company's independent registered public accounting firm for the year ended December 31, 2016;
10.To authorize the Board to make repayments of equity at times and in amounts set by the Board in its discretion and within the limits of Luxembourg law;
11.To authorize the repurchase up to 4.5 million ordinary shares over the next two (2) years;
12.Any other business properly brought before the Annual General Meeting of Shareholders.
|